Article · 28 Jun 2025
ArticlePublished 2016
and#946;2-Adrenoceptors Antiarrhythmic Effects in Wild Type Mice Fed a Cholesterol-Enriched Diet
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The systematic intake of an unbalanced diet is an important risk factor for cardiovascular diseases, the leading cause of death in the entire world. Most of the studies address this issue using genetically manipulated mice. This study aims to investigate the effect of the intake of a cholesterol-enriched diet on cardiac and hemodynamic parameters in conscious wild type mice. Twenty male, three-month-old C57BL/6 mice were distributed in two groups: (CTL) control, with mice receiving standard commercial chow and (CHO) cholesterol group, with mice receiving a cholesterol-enriched diet during 15 days. Catheters were implanted in the carotid artery and jugular vein for blood pressure and heart rate recording and drugs administration. Electrodes were implanted for electrocardiogram recording and spectral analysis of heart rate variability. Glucose, cholesterol, and triglycerides were determined in blood samples and histopathological analysis of the aorta was performed. Serum cholesterol and glucose, mean arterial pressure and heart rate were higher in CHO than CTL mice. CHO mice also exhibited a predominance of sympathetic over parasympathetic tonus to the heart and higher responsiveness to the chronotropic effect of isoproterenol. Arrhythmic episodes, present only in the CHO mice, were canceled by metoprolol and exacerbated by ICI118,551. It is concluded that the intake of high cholesterol diet causes hypertension and heart rhythm irregularities. Because those effects are exacerbated by the blockade of the β2-adrenergic receptor and attenuated by the blockade of the β1-adrenergic receptor, data highlights a possible antiarrhythmic protective role played by β2-AR subtype.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cardiovascular Pharmacology: Open Access.
Article · 28 Jun 2025
Beta Blockers and Their Expanding Role in Cardiovascular Disease
Article · 28 Jun 2025
Emerging Role of PCSK9 Inhibitors in Lipid Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Pharmacology: Open Access
- SubjectPharmaceutical Sciences
- SubjectCardiology
- BylineArticles whose byline prints “Simone Correia Ternes”
- BylineArticles whose byline prints “Leandro Eziquiel de Souza”
- BylineArticles whose byline prints “Paula Lazara Cruz”
- BylineArticles whose byline prints “Cristiano Teixeira Mostarda”
- BylineArticles whose byline prints “Maria Cláudia Costa Irigoyen”
- BylineArticles whose byline prints “Vitor Rossi de Almeida”
- BylineArticles whose byline prints “André Luiz de Moura”
- BylineArticles whose byline prints “Luciana Le Sueur Maluf”
